Trials / Unknown
UnknownNCT01710436
Relationship Between Dosage of Clopidogrel and Platelet Aggregation in Chinese With Different Genotype
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 880 (estimated)
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective, observational study to estimate the relationship between dosage of clopidogrel and platelet aggregation in Chinese with different genotype. The investigators suppose both pretreatment dosage of clopidogrel before percutaneous coronary intervention (PCI) and CYP2C19 genotype may effect the platelet aggregation as well as clinical outcome.
Conditions
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-11-01
- First posted
- 2012-10-19
- Last updated
- 2013-05-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01710436. Inclusion in this directory is not an endorsement.